Risk factors and cardiovascular disease in Turkey

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 1-10

  Onat, Altan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cardiovascular risk factors; Coronary heart disease; HDL cholesterol; Lipoproteins; Metabolic syndrome; Serum lipids; Turkish adults

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LIVER TRIACYLGLYCEROL LIPASE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME BLOOD LEVEL; FEMALE; HEART PROTECTION; HUMAN; HYPERTENSION; IMMOBILIZATION; INDUSTRIALIZATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC BALANCE; MORBIDITY; MORTALITY; OBESITY; POPULATION STRUCTURE; PREDICTION; PRIORITY JOURNAL; REVIEW; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; HUMANS; HYPERTENSION; LIPIDS; LIPOPROTEINS; MORBIDITY; RISK FACTORS; SMOKING; TURKEY;

EID: 0035003040     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00500-7     Document Type: Review

References (36)

1. Reddy K.S. Ethnic diversity: the new challenge of preventive cardiology. CVD Prevent. 1:1998;6-8.
2. Mahley R.W., Palaoglu E., Atak Z., et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J. Lipid Res. 36:1995;839-859.
3. Onat A., Sansoy V., Soydan I., Tokgözoglu L., Adalet K. Türk Eriskinlerinde Kalp Sagligi, Risk Profili ve Kalp Hastaligi. 2000;96 Ohan, Istanbul.
4. Onat A., Surdum-Avci G., Senocak M., Örnek E., Gözükara Y. Plasma lipids and their interrelationship in Turkish adults. J. Epidemol. Commun. Health. 46:1992;470-476.
5. Onat A, Keles I, Çetinkaya A, et al. Prevalence of all-cause and coronary mortality in Turkish adults as assessed by 10-year follow-up data of the Turkish adult risk factor study. Arch Turk Soc Cardiol 2001;29:8-19 [in Turkish, summary in English].
6. Onat A., Dursunoglu D., Sansoy V. Relatively high coronary death and event rates in Turkish women: relation to three major risk factors in five-year follow-up of cohort. Int. J. Cardiol. 61:1997;69-78.
7. Institute of Medicine. Control of Cardiovascular Diseases in Developing Countries: Research, Development and Institutional Strengthening. Washington, DC: National Academy Press, 1998.
8. Sans S, Kesteloot H, Kromhout D, on behalf of the Task Force. The burden of cardiovascular disease mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics. Eur Heart J 1997;18:1231-1248.
9. Onat A., Senocak M., Avci G.S., Örnek E. Prevalence of coronary heart disease in Turkish adults. Int. J. Cardiol. 39:1993;23-31.
10. Assmann G., Cullen P., Schulte H. The Münster Heart Study (PROCAM): results of follow-up at 8 years. Eur. Heart J. 19:(suppl A):1998;A2-A11.
11. Johnson C.L., Rifkind B.M., Sempos C.T., Carroll M.D., Bachorik P.S., Briefel R.R., Gordon D.J., Burt V.L., Brown C.D., Lippel K., Cleeman J.I. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. J. Am. Med. Assoc. 269:1993;3002-3008.
12. Miller M. Is hypertriglyceridaemia an independent risk factor for coronary heart disease? The epidemiological evidence. Eur. Heart J. 19:(suppl H):1998;H18-H22.
13. Contois J.H., McNamara J.R., Lammi-Keefe C.J., Wilson P.W., Massov T., Schaefer E.J. Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin. Chem. 42:1996;507-514.
14. Onat A., Yildirim B., Uslu N., et al. Plasma lipoproteins and apolipoproteins in Turkish adults: overall levels, association with other risk parameters, and HDL's role as a marker of coronary risk in women. Arch. Turk. Soc. Cardiol. 27:1999;72-79.
15. Onat A., Ceyhan K., Hergenç G., et al. Apolipoprotein C-III levels and interrelation with other risk factors in residents of the Marmara region. Arch. Turk. Soc. Cardiol. 29:2001;136-142. [in Turkish, summary in English].
16. Onat A., Sansoy V., Uysal Ö. Waist circumference and waist-to-hip ratio in Turkish adults: interrelation with other risk factors and association with cardiovascular disease. Int. J. Cardiol. 70:1999;43-50.
17. Bersot T.P., Vega G.L., Grundy S.M., Palaoglu K.E., Atagündüz P., Özbayrakçi S., Gökdemir O., Mahley R.W. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J. Lipid Res. 40:1999;432-438.
18. Contois J.H., McNamara J.R., Lammi-Keefe C.J., Wilson P.W., Massov T., Schaefer E.J. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin. Chem. 42:1996;515-523.
19. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation. 97:1998;1837-1847.
20. Onat A., Sansoy V., Yildirim B. Which fasting triglyceride levels best reflect coronary risk? Evidence from the Turkish Adult Risk Factor Study. Clin. Cardiol. 24:2001;9-14.
21. Jeppesen J., Hein H.O., Saudicani P., Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 97:1998;1029-1036.
22. Campos H., Genest J.J., Blijlevens E., et al. Low density lipoprotein particle size and coronary artery disease. Atheroscler. Thromb. 12:1992;187-195.
23. Griffin B.A., Freeman D.J., Tait G.W., et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 106:1994;241-253.
24. van den Hoogen P.C.W., Feskens E.J.M., Nagelkerke N.J.D., Menotti A. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. New Eng. J. Med. 342:2000;1-8.
25. Benetos A., Thomas F., Safar M.E., Bean K.E., Guize L. Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and women. J. Am. Coll. Cardiol. 37:2001;163-168.
26. Onat A., Sansoy V., Yildirim B., et al. Blood pressure levels in Turkish adults: 8-year trends, rate of treatment, relationship to other risk factors and to coronary disease. Arch. Turk. Soc. Cardiol. 27:1999;136-142.
27. Grundy S.M., Greenland P., Herd A., et al. Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association. Circulation. 75:1987;1340A-1362A.
28. Onat A., Çetinkaya A., Sansoy V., Yildirim B., Keles I. Surge in prevalence of diabetes mellitus among Turkish adults: excess coronary risk in subjects with impaired glucose tolerance. Arch. Turk. Soc. Cardiol. 28:2000;20-26.
29. Onat A. Obesity in Turkish adults: prevalence, validity as coronary risk factor and interrelation with other risk factors. Int. J. Angiol. 4:1995;94-98.
30. World Health Organization (WHO). Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organization, 1998.
31. Onat A., Sansoy V. Systolic and diastolic blood pressure related to six other risk parameters in Turkish adults: strong correlation with relative weight. Int. J. Cardiol. 63:1998;295-303.
32. Onat A., Senocak M.S. Relative risk of factors for coronary heart disease in population with low cholesterol levels. Int. J. Cardiol. 43:1994;51-60.
33. Pate R.R., Pratt M., Blair S.N., et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. J. Am. Med. Assoc. 273:1995;402-407.
34. Onat A, Sansoy V, Yildirim B, Keles, Uysal Ö, Hergenç G. C-reactive protein, independent of conventional risk factors, is a powerful determinant of prevalent coronary heart disease in population with low cholesterol levels. (Submitted).
35. Ernst E., Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann. Intern. Med. 118:1993;956-963.
36. Tokgözoglu S.L., Alikasifoglu M., Ünsal I., et al. Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate. Heart. 81:1999;518-522.